These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27466921)

  • 1. The FDA Revises Restrictions on Metformin Use in Kidney Impairment.
    Aschenbrenner DS
    Am J Nurs; 2016 Aug; 116(8):22-3. PubMed ID: 27466921
    [No Abstract]   [Full Text] [Related]  

  • 2. Using metformin in the presence of renal disease.
    Chowdhury TA; Wright R; Yaqoob MM
    BMJ; 2015 Apr; 350():h1758. PubMed ID: 25873532
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin in renal failure--weigh the evidence.
    Mani MK
    Nephrol Dial Transplant; 2009 Jul; 24(7):2287-8. PubMed ID: 19390119
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin therapy in patients with type 2 diabetes complicated by heart failure.
    Inzucchi SE; Masoudi FA; McGuire DK
    Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment with metformin in type 2 diabetes mellitus - new routines when renal function is reduced and in connection with administration of iodine contrast media].
    Sterner G; Frid A
    Lakartidningen; 2018 Apr; 115():. PubMed ID: 29634072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing nephropathy induced by contrast medium.
    Gross JL; Friedman R; Silveiro SP
    N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16641408
    [No Abstract]   [Full Text] [Related]  

  • 7. Metformin for patients with diabetes and concomitant renal restrictions--is there an evidence base?
    Sharif A
    QJM; 2013 Mar; 106(3):291-4. PubMed ID: 23349404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin.
    Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA
    Arch Intern Med; 2011 Jun; 171(11):1042-3; author reply 1043. PubMed ID: 21670379
    [No Abstract]   [Full Text] [Related]  

  • 9. Unleash metformin: reconsideration of the contraindication in patients with renal impairment.
    Lu WR; Defilippi J; Braun A
    Ann Pharmacother; 2013 Nov; 47(11):1488-97. PubMed ID: 24259604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antidiabetic agents safe with renal disease?
    Bakris G
    Postgrad Med; 2000 Jun; 107(7):66. PubMed ID: 10887446
    [No Abstract]   [Full Text] [Related]  

  • 11. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].
    Pinto D; Heleno B; Gallego R; Santos I; Santiago LM; Maria V
    Acta Med Port; 2011; 24(2):331-8. PubMed ID: 22011607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
    Almirall J; Bricullé M; Gonzalez-Clemente JM
    Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metformin and lactic acidosis--fact or fiction? A review of current data].
    Bläuer SC; Keller U
    Praxis (Bern 1994); 2003 Nov; 92(47):2008-10. PubMed ID: 14669502
    [No Abstract]   [Full Text] [Related]  

  • 15. Metformin in type 2 diabetes.
    Fox GN
    J Fam Pract; 2004 Nov; 53(11):900. PubMed ID: 15527727
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications.
    Flory JH; Hennessy S
    JAMA Intern Med; 2015 Mar; 175(3):458-9. PubMed ID: 25561419
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metformin and anesthesia].
    Landgraf R; Nawroth PP
    Anaesthesist; 2002 Jun; 51(6):491-2. PubMed ID: 12452166
    [No Abstract]   [Full Text] [Related]  

  • 18. MALAdaptive: do we avoid metformin unnecessarily?
    Terpening C
    J Am Board Fam Med; 2014; 27(1):136-41. PubMed ID: 24390895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowering C-peptide levels and renoprotective therapy.
    Clouâtre Y
    Kidney Int; 2000 Jun; 57(6):2655-6. PubMed ID: 10844641
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for metformin-associated lactic acidosis.
    Beis SJ; Goshman LM; Newkirk GL
    WMJ; 1999; 98(4):56-7. PubMed ID: 10555481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.